121 related articles for article (PubMed ID: 15191399)
1. Inhibition of the dopamine system in rat amygdala attenuates the picrotoxin-induced locomoter hyperactivity and hypertension.
Chang CK; Wang NL; Lin MT
Clin Exp Pharmacol Physiol; 2004; 31(5-6):284-8. PubMed ID: 15191399
[TBL] [Abstract][Full Text] [Related]
2. Antagonistic effects of stimulation of the paramedian reticular nucleus in the rat medulla oblongata and of amphetamine on locomotor activity and striatal release of dopamine-like material.
Lin MT; Chuang SF; Li YC; Young MS; Chai CY
Naunyn Schmiedebergs Arch Pharmacol; 1993 Sep; 348(3):258-63. PubMed ID: 8232603
[TBL] [Abstract][Full Text] [Related]
3. Prefrontal cortex and basolateral amygdala modulation of dopamine-mediated locomotion in the nucleus accumbens core.
Rouillon C; Abraini JH; David HN
Exp Neurol; 2008 Jul; 212(1):213-7. PubMed ID: 18501353
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of postsynaptic alpha1b- and alpha2-adrenergic receptors amplifies dopamine-mediated locomotor activity in both rats and mice.
Villégier AS; Drouin C; Bizot JC; Marien M; Glowinski J; Colpaërt F; Tassin JP
Synapse; 2003 Dec; 50(4):277-84. PubMed ID: 14556232
[TBL] [Abstract][Full Text] [Related]
5. DL-Tetrahydropalmatine may act through inhibition of amygdaloid release of dopamine to inhibit an epileptic attack in rats.
Chang CK; Lin MT
Neurosci Lett; 2001 Jul; 307(3):163-6. PubMed ID: 11438389
[TBL] [Abstract][Full Text] [Related]
6. Antagonistic effects of lesions of paramedian reticular nucleus on amphetamine-induced locomotion and striatal dopamine release in rats.
Chiu WT; Lin LS; Lin MT
Neurosci Res; 1993 May; 16(4):311-4. PubMed ID: 8394558
[TBL] [Abstract][Full Text] [Related]
7. Picrotoxin induces both hypertension and dopamine release in the rat amygdala.
Chu TF; Lin MT
Neurosci Lett; 1996 Nov; 218(3):169-72. PubMed ID: 8945755
[TBL] [Abstract][Full Text] [Related]
8. Dietary cadmium exposure attenuates D-amphetamine-evoked [3H]dopamine release from striatal slices and methamphetamine-induced hyperactivity.
Miller DK; Dopheide MM; Smith SM; Casteel SW
Pharmacol Biochem Behav; 2005 Apr; 80(4):557-66. PubMed ID: 15820525
[TBL] [Abstract][Full Text] [Related]
9. Blockade of group II metabotropic glutamate receptors produces hyper-locomotion in cocaine pre-exposed rats by interactions with dopamine receptors.
Yoon HS; Jang JK; Kim JH
Neuropharmacology; 2008 Sep; 55(4):555-9. PubMed ID: 18675831
[TBL] [Abstract][Full Text] [Related]
10. The interaction between locomotion, striatal dopamine and paramedian reticular nucleus in rats.
Chuang SF; Chai CY; Lin MT
Neurosci Lett; 1993 Sep; 159(1-2):127-30. PubMed ID: 8264953
[TBL] [Abstract][Full Text] [Related]
11. Possible involvement of protease-activated receptor-1 in the regulation of morphine-induced dopamine release and hyperlocomotion by the tissue plasminogen activator-plasmin system.
Ito M; Nagai T; Mizoguchi H; Fukakusa A; Nakanishi Y; Kamei H; Nabeshima T; Takuma K; Yamada K
J Neurochem; 2007 Jun; 101(5):1392-9. PubMed ID: 17286591
[TBL] [Abstract][Full Text] [Related]
12. Disruption of G(i/o) protein signaling in the nucleus accumbens results in a D1 dopamine receptor-mediated hyperactivity.
Schroeder JA; Hummel M; Unterwald EM
Pharmacol Biochem Behav; 2004 Sep; 79(1):93-9. PubMed ID: 15388288
[TBL] [Abstract][Full Text] [Related]
13. Effect of ginseng saponins on enhanced dopaminergic transmission and locomotor hyperactivity induced by nicotine.
Kim SE; Shim I; Chung JK; Lee MC
Neuropsychopharmacology; 2006 Aug; 31(8):1714-21. PubMed ID: 16251992
[TBL] [Abstract][Full Text] [Related]
14. Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors.
Auclair A; Blanc G; Glowinski J; Tassin JP
J Neurochem; 2004 Oct; 91(2):318-26. PubMed ID: 15447665
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D1 or D2 receptor antagonism within the basolateral amygdala differentially alters the acquisition of cocaine-cue associations necessary for cue-induced reinstatement of cocaine-seeking.
Berglind WJ; Case JM; Parker MP; Fuchs RA; See RE
Neuroscience; 2006; 137(2):699-706. PubMed ID: 16289883
[TBL] [Abstract][Full Text] [Related]
16. Increased dopamine release in vivo by estradiol benzoate from the central amygdaloid nucleus of Parkinson's disease model rats.
Liu B; Xie J
J Neurochem; 2004 Aug; 90(3):654-8. PubMed ID: 15255943
[TBL] [Abstract][Full Text] [Related]
17. Effects of morphine on rat behaviour in the elevated plus maze: the role of central amygdala dopamine receptors.
Rezayof A; Hosseini SS; Zarrindast MR
Behav Brain Res; 2009 Sep; 202(2):171-8. PubMed ID: 19463698
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic regulation of orexin neurons.
Bubser M; Fadel JR; Jackson LL; Meador-Woodruff JH; Jing D; Deutch AY
Eur J Neurosci; 2005 Jun; 21(11):2993-3001. PubMed ID: 15978010
[TBL] [Abstract][Full Text] [Related]
19. L-DOPA attenuates hyperactivity of Roborovskii hamsters.
Kabuki Y; Shigemi K; Hamasu K; Furuse M
Behav Pharmacol; 2009 May; 20(3):260-4. PubMed ID: 19404194
[TBL] [Abstract][Full Text] [Related]
20. 2-Chloro-N-[(S)-phenyl [(2S)-piperidin-2-yl] methyl]-3-trifluoromethyl benzamide, monohydrochloride, an inhibitor of the glycine transporter type 1, increases evoked-dopamine release in the rat nucleus accumbens in vivo via an enhanced glutamatergic neurotransmission.
Leonetti M; Desvignes C; Bougault I; Souilhac J; Oury-Donat F; Steinberg R
Neuroscience; 2006; 137(2):555-64. PubMed ID: 16289893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
